Your browser doesn't support javascript.
loading
Pru du 1, the Bet v 1-homologue from almond, is a major allergen in patients with birch pollen associated almond allergy.
Kabasser, Stefan; Crvenjak, Nadja; Schmalz, Stefanie; Kalic, Tanja; Hafner, Christine; Dubiela, Pawel; Kucharczyk, Aleksandra; Bazan-Socha, Stanislawa; Lukaszyk, Mateusz; Breiteneder, Heimo; Radauer, Christian; Bublin, Merima.
Afiliação
  • Kabasser S; Institute of Pathophysiology and Allergy Research Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna Vienna Austria.
  • Crvenjak N; Institute of Pathophysiology and Allergy Research Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna Vienna Austria.
  • Schmalz S; Institute of Pathophysiology and Allergy Research Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna Vienna Austria.
  • Kalic T; Institute of Pathophysiology and Allergy Research Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna Vienna Austria.
  • Hafner C; Department of Dermatology University Hospital St. Pölten Karl Landsteiner University of Health Sciences St. Pölten Austria.
  • Dubiela P; Department of Dermatology University Hospital St. Pölten Karl Landsteiner University of Health Sciences St. Pölten Austria.
  • Kucharczyk A; Karl Landsteiner Institute for Dermatological Research St. Pölten Austria.
  • Bazan-Socha S; Institute of Pathophysiology and Allergy Research Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna Vienna Austria.
  • Lukaszyk M; Department of Regenerative Medicine and Immune Regulation Medical University of Bialystok Bialystok Poland.
  • Breiteneder H; Department of Internal Diseases, Pneumonology, Allergology Clinical Immunology, Military Institute of Medicine Warsaw Poland.
  • Radauer C; Department of Internal Medicine Jagiellonian University Medical College Krakow Poland.
  • Bublin M; Department of Lung Diseases and Tuberculosis Medical University of Bialystok Bialystok Poland.
Clin Transl Allergy ; 12(8): e12177, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35949989
ABSTRACT

Background:

Almond allergy is common and can manifest in two different forms. Primary almond allergy has been reported to be associated with sensitization to almond legumin Pru du 6. In birchendemic regions, there is a link between birch-pollinosis which is likely based on a cross-reactive Bet v 1 homologue, a yet unidentified allergen in almond. Therefore, we sought to identify and characterize a Bet v 1-homologue in almond.

Methods:

The expression of a Bet v 1 homologue in almond kernels was confirmed by mass spectrometry. The recombinant protein was produced in Escherichia coli and its cross-reactivity and allergenic potency was analyzed by IgE quantitative and competitive ELISA, immunoblotting and basophil histamine release using sera from 17 almond allergic patients.

Results:

The identified Bet v 1 homologue received the designation Pru du 1.0101. Pru du 1.0101 bound IgE from 82 % of almond allergic patients. Bet v 1 was able to inhibit IgE-binding to rPru du 1 by 100%, while rPru du 1 inhibited IgE binding to rBet v 1 by 48%. Pru du 1.0101 activated basophils, though 100- to 1000-fold higher concentrations were required for maximum activation in comparison to rBet v 1.

Conclusion:

Considering the strong inhibition capacity and higher allergenic potency of Bet v 1, the results provide compelling evidence for primary sensitization to Bet v 1 in case of birch pollen associated almond allergy. Combining Pru du 6 and Pru du 1 in diagnostic approaches may help to discriminate between primary and birch-pollen associated almond allergy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2022 Tipo de documento: Article